Clinical use of S-HER2 in breast cancer for detecting metastatic recurrence and monitoring effect of trastuzumab treatment

Ina Mathilde Kjær*, Ivan Brandslund

*Corresponding author for this work

Research output: Contribution to journalJournal articleResearchpeer-review

Fingerprint Dive into the research topics of 'Clinical use of S-HER2 in breast cancer for detecting metastatic recurrence and monitoring effect of trastuzumab treatment'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds